Foresight Diagnostics

Developer of minimally-invasive liquid biopsy test for the detection of cancer

placeAurora, Colorado, United States calendar_todayFounded 2020 groups35 employees language foresight-dx.com

Innovation

3 patent families — focus: Physics & computing, Chemistry & metallurgy; filing pace active. Cited 9 times.

YearFilings
20252
20261

Social engagement

Social engagement: 10.5K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Civilization Ventures, Bluebird Ventures, Pear VC, Foresite Capital.

Investor typeCountShare
Venture capital788%
Other / undisclosed113%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

10 Jun 2026 · Program Manager · Aurora

11 Sep 2025 · Clinical Research Associate (0111) · Boulder

6 Sep 2025 · Senior Director, Information Technology · Boulder

6 Sep 2025 · Senior Specialist, Regulatory Affairs · Boulder

Based on job postings tracked across public sources.

Recent activity

24 Feb 2026
Event
webinar on circulating tumor DNA (#ctDNA) as a highly sensitive biomarker for molecular residual disease (#MRD) in lymphoma
2 Feb 2026
Event
Precision Oncology Summit
7 Dec 2025
Event
ASH2025 Oral Presentation on Real-World Data on Ultrasensitive MRD Surveillance
Coming soon